August 21, 2018 | FAH Policy Blog Team
Category: FAH News, Legislation, Pharmaceuticals
Rising and excessive drug prices threaten patient access to the drugs they need and can undermine the care physicians see as necessary for patients. The Grassley-Durbin amendment (#3787) would take a great leap forward in providing consumers useful information on drug prices that could help them buy smart. And, the public display of prices could put a spotlight on those high prices and bring them down.
August 20, 2018 | FAH Policy Blog Team
Category: FAH News
FAH and its company leaders are strongly represented on the just released 2018 “100 Most Influential People in Healthcare” list from Modern Healthcare. The annual ranking is a collaboration between the magazine’s senior editors and readers. After a nomination process, readers pick their favorites from a preliminary ballot of 300. The final rankings take into account vote totals and input from the senior editors.
July 25, 2018 | FAH Policy Blog Team
LifePoint Health’s National Quality Program (NQP) was featured in the July 2018 issue of The Joint Commission Journal on Quality and Patient Safety, a nationally recognized peer-reviewed journal publication.
July 18, 2018 | Chip Kahn
Category: Health Care Delivery, Medicaid, Medicare
“A fresh take on health care is certainly called for and Adam brings that to this new and important position. He has been an actual innovator in health care, working in the real world, looking for new ways to serve patients and their families better as well as making caregiving more efficient and effective.
- FAH Comments on Senators Grassley and Durbin Drug Pricing Amendment
- Modern Healthcare Honors FAH’s Chip Kahn, Several Members on Annual “100 Most Influential” List
- LifePoint Health’s National Quality Program Featured in Peer Reviewed Journal
- FAH Leader: Boehler is a Real World Innovator, Well Suited for New Role